Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 12 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Monopar Therapeutics | 50,726 | reported | 31 Dec 2025 | tx 68+798,248−121,085 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 31 Dec 2025 | EXERCISE | Monopar Therapeutics | 4,326 | — | |
| 31 Dec 2025 | TAX_WITHHOLDING | Monopar Therapeutics | 1,889 | 65.30 USD | |
| 31 Dec 2025 | EXERCISE | Monopar Therapeutics | 4,326 | 0.00 USD | deriv |
| 02 Dec 2025 | GRANT_AWARD | Monopar Therapeutics | 8,969 | 0.00 USD | deriv |
| 02 Dec 2025 | GRANT_AWARD | Monopar Therapeutics | 13,919 | 0.00 USD | deriv |
| 30 Sept 2025 | EXERCISE | Monopar Therapeutics | 4,327 | — | |
| 30 Sept 2025 | TAX_WITHHOLDING | Monopar Therapeutics | 1,896 | 81.67 USD | |
| 30 Sept 2025 | EXERCISE | Monopar Therapeutics | 4,327 | 0.00 USD | deriv |
| 30 Jun 2025 | TAX_WITHHOLDING | Monopar Therapeutics | 2,990 | 35.78 USD | |
| 30 Jun 2025 | EXERCISE | Monopar Therapeutics | 6,863 | — | |
| 30 Jun 2025 | EXERCISE | Monopar Therapeutics | 6,863 | 0.00 USD | deriv |
| 31 Mar 2025 | EXERCISE | Monopar Therapeutics | 1,791 | — | |
| 31 Mar 2025 | TAX_WITHHOLDING | Monopar Therapeutics | 744 | 36.41 USD | |
| 31 Mar 2024 | EXERCISE | Monopar Therapeutics | 1,791 | 0.00 USD | deriv |
| 04 Mar 2025 | GRANT_AWARD | Monopar Therapeutics | 43,445 | 0.00 USD | deriv |
| 04 Mar 2025 | GRANT_AWARD | Monopar Therapeutics | 40,581 | 0.00 USD | deriv |
| 31 Dec 2024 | EXERCISE | Monopar Therapeutics | 1,790 | — | |
| 31 Dec 2024 | TAX_WITHHOLDING | Monopar Therapeutics | 721 | 22.00 USD | |
| 31 Dec 2024 | EXERCISE | Monopar Therapeutics | 1,790 | 0.00 USD | deriv |
| 30 Sept 2024 | EXERCISE | Monopar Therapeutics | 1,791 | — | |
| 30 Sept 2024 | TAX_WITHHOLDING | Monopar Therapeutics | 535 | 6.74 USD | |
| 30 Sept 2024 | EXERCISE | Monopar Therapeutics | 1,791 | 0.00 USD | deriv |
| 30 Jun 2024 | TAX_WITHHOLDING | Monopar Therapeutics | 2,019 | 0.73 USD | |
| 30 Jun 2024 | EXERCISE | Monopar Therapeutics | 8,952 | — | |
| 30 Jun 2024 | EXERCISE | Monopar Therapeutics | 8,952 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 29 May 2024.